OTC · Drug Manufacturers - Specialty & Generic

Pharmadrug Inc. (LMLLF) Stock

$0.01 +17.46% OTC: LMLLF Healthcare

Pharmadrug Inc. operates as a specialized pharmaceutical company, primarily dedicated to the exploration, development, and commercialization of controlled substances and naturally derived therapeutic agents.

Valuation

MetricValue
Price$0.01
Market Cap$993184
P/E Ratio-2.33
P/B Ratio-0.86
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.02
52-Week Low$0.00
Dividend Yield—

Financials & Margins

MetricValue
ROE28.90%
ROA-51.77%
ROCE19.10%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-1.03
Current Ratio0.20

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-2.0M$-1.0M$-1.0M$0
Net Profit$-6.0M$-9.0M$-13.0M$-1.0M$0
EPS$-0.12$-0.06$-0.23$-0.01$0.00
Op Margin-38578.1%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$20.0M$12.0M$1.0M$1.0M$1.0M
Total Liabilities$3.0M$3.0M$3.0M$2.0M$2.0M
Cash$1.0M$0$0$0$0
Borrowings$1.0M$1.0M$2.0M$1.0M$2.0M

Latest News

PharmaTher's Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus TMX Newsfile · May 13, 2026 PharmaDrug Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus TMX Newsfile · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-2.0M$-1.0M$-1.0M$0
Investing Cash Flow$1.0M$0$1.0M$0$0
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$-1.0M$-1.0M$1.0M$0$0
Free Cash Flow$-4.0M$-2.0M$-1.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA—
FCF Yield0.00%
Quick Ratio0.20
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.88%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOEBio Essence Corporation $0.25 +37.44% 7.44 $9.90M 0.00%
CNGGFCann Group Limited $0.00 — 0.27 $2.40M 0.00%
CPMDCannaPharmaRX, Inc. $0.00 — -0.13 $1.42M 0.00%
NRPRResilient Healthcare Corp $0.02 +0.00% — $2.11M 0.00%
RAFARafarma Pharmaceuticals, Inc. $0.02 +0.00% 10.43 $2.11M 0.00%

About Pharmadrug Inc.

Pharmadrug Inc. operates as a specialized pharmaceutical company, primarily dedicated to the exploration, development, and commercialization of controlled substances and naturally derived therapeutic agents. Its portfolio encompasses novel compounds like psychedelics and cannabis, alongside other naturally sourced approved medicines. Beyond its core research and development activities, the firm plays a crucial role in importing and distributing medical cannabis to pharmacies across Germany and the broader European Union. The company also oversees Super Smart, an initiative focused on promoting and exploring the benefits of functional and psilocybin mushrooms. Additionally, Pharmadrug actively engages in researching and enhancing established natural remedies. Significant research collaborations underpin its innovative pipeline, including an agreement with the University of Michigan to assess N, N-dimethyltryptamine's (DMT) role in various conscious states. Another partnership with the Southwest Research Institute is geared towards the non-clinical and clinical manufacturing of cepharanthine. Furthermore, a clinical trial agreement with Johns Hopkins University facilitates a study comparing the acute and enduring psychological and neural effects of DMT against an undisclosed, highly active comparator molecule. Headquartered in Toronto, Canada, the company adopted its current name, Pharmadrug Inc., in October 2019, having previously operated as Aura Health Inc.

Pharmadrug Inc. is headquartered in CA.

Pharmadrug Inc. (LMLLF) stock trades at $0.01 with a market capitalization of $993184. The stock is valued at a price-to-earnings (P/E) ratio of -2.33, price-to-book of -0.86, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 50.0% below its 52-week high.

On profitability, Pharmadrug Inc. generates a return on equity (ROE) of 28.90% — well above the market average, a sign of a high-quality business, return on capital employed of 19.10%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.pharmadrug.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides